首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Propyl Starch Derivatives enable a Controlled and Sustained Release of Hydrophobic Drugs inDependence on the Degree of Hydrophobic Modification
【24h】

Propyl Starch Derivatives enable a Controlled and Sustained Release of Hydrophobic Drugs inDependence on the Degree of Hydrophobic Modification

机译:丙基淀粉衍生物可根据疏水性修饰程度控制和持续释放疏水性药物

获取原文
获取外文期刊封面目录资料

摘要

Maize starch hydrophobically modified by covalentbinding of propyl chains has been used as raw material forthe preparation of novel drug delivery systems.Specifically, two starch derivatives with a degree ofsubstitution (Ds) of 1.07 (PS 1) and 1.45 (PS 1.45) wereselected to prepare the nanoparticles by an emulsiondiffusionprocess. Afterwards, nanoparticles werephysicochemically characterized showing nanometric sizeand low polydispersity. Both systems had highencapsulation efficiency (EE) for the tested drugs(Flufenamic acid, Testosterone and Caffeine),independently of the physicochemical characteristics ofthe encapsulated drug. Nevertheless, the hydrophobicinteractions drug-polymer had a clear influence on therelease profile, showing the hydrophobic drugs a close tolinear release avoiding the undesirable initial burst effect.
机译:玉米淀粉经共价疏水改性 丙基链的结合已被用作 新型药物传递系统的制备。 具体来说,两种淀粉衍生物的程度为 替代(Ds)为1.07(PS 1)和1.45(PS 1.45) 选择通过乳液扩散制备纳米颗粒 过程。之后,纳米粒子被 物理化学表征显示出纳米级尺寸 和低多分散性。两个系统都有很高的 被测药物的包封效率(EE) (氟苯那酸,睾丸激素和咖啡因), 与...的理化特性无关 封装的药物。尽管如此,疏水性 药物-聚合物之间的相互作用对 释放曲线,表明疏水性药物接近 线性释放避免了不良的初始爆发效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号